Atezolizumab prolongs overall survival over docetaxel in advanced non-small-cell lung cancer patients harboring STK11 or KEAP1 mutation
Keyword(s):
2016 ◽
Vol 96
(2)
◽
pp. E465-E466
Keyword(s):
2013 ◽
Vol 32
(1)
◽
pp. 45
◽
Keyword(s):
Keyword(s):
2016 ◽
Vol 11
(11)
◽
pp. 1927-1939
◽
Keyword(s):
Keyword(s):
2012 ◽
Vol 84
(3)
◽
pp. S578
◽
2017 ◽
Vol 27
(3)
◽
pp. 120-123
◽
Keyword(s):